Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigious | ||
Readability |
H.S. sophomore Avg
|
New words:
Aczone®and, aerosol, Akorn, Apollo, Arabia, austerity, Authorisation, Azzalure®or, Belgium, CADIVI, canister, cheek, Chile, Citizen, clarification, construction, CRL, Daewoong, darker, deep, deposit, depression, devaluation, dose, dosing, double, du, Egypt, eighteen, ejaculation, Endosurgery, Exemplar, exit, extraordinarily, Fall, female, fluctuate, fluctuation, fluid, frown, fuller, FusionTM, gabellar, henri, Iceland, Indonesia, Innotox, Israel, Kuwait, lipid, loading, loyalty, male, Medford, Medytox, Nabota, Nationale, nineteen, Norway, PlusTM, premature, proceed, ranibizumab, ratio, rejuvenate, relaxant, River, role, Sant, Saudi, scaffold, scalp, Semnur, Seri, shareholder, shortfall, shut, Slovakia, strictly, technonology, termeer, transitory, unrelated, unwanted, variation, Venezuela, Venezuelan, Vietnam, yen
Removed:
adjustable, Alphagan®P, AP, Avanir, backup, banc, banding, bariatric, benign, bioform, birth, Blue, BMI, boyer, burn, carrier, Chancery, chloride, closure, comorbid, conservative, deceptive, differential, discontinuation, EndoArt, endoscopically, Ethicon, evenly, eventually, FGIA, fourteen, gastrectomy, grafting, GSK, guarantee, Helioscopie, herbert, hyperplasia, impairing, incision, ineffective, insertion, intragastric, laparoscopically, Louisiana, minimally, morbidly, Municipal, neuropathic, nighttime, notably, obese, offense, overweight, passage, Personalized, pouch, prospectively, prostatic, reacquisition, receipt, recur, remote, reset, ryan, SA, Samil, sensation, Shield, sleeve, Southern, Spatz, Squibb, step, stephen, stomach, tender, Teva, Transnational, transoral, trospium, unsuccessfully, urge, Vermont, volumizing, weight, work, workforce
Filing tables
Filing exhibits
- 10-K Annual report
- 10.14 Exhibit 10.14
- 10.19 Exhibit 10.19
- 10.20 Exhibit 10.20
- 10.30 Exhibit 10.30
- 10.40 Exhibit 10.40
- 10.41 Exhibit 10.41
- 10.42 Exhibit 10.42
- 10.43 Exhibit 10.43
- 10.44 Exhibit 10.44
- 21 Exhibit 21
- 23.1 Exhibit 23.1
- 31.1 Exhibit 31.1
- 31.2 Exhibit 31.2
- 32 Exhibit 32
- Download Excel data file
- View Excel data file
Related press release
Allergan similar filings
Filing view
External links